Dr. Edward P. Havranek, MD

Dr. Havranek practices at Denver Health Medical Center in Denver, Colorado, part of Denver Health and Hospital Authority.

Dr. Havranek's NPI, 1326062092, was assigned on July 27, 2006. Dr. Havranek graduated from University of Vermont College of Medicine in 1983. Dr. Havranek holds Colorado license DR.0026367.

Dr. Havranek's primary practice is Denver Health Medical Center, at 777 Bannock St, Denver, CO 80204 in Denver County. The practice phone is (303) 602-4935.

Dr. Havranek's primary practice is Denver Health Medical Center in Denver, Colorado, part of Denver Health and Hospital Authority. The medical group on file is Denver Health. Dr. Havranek's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Havranek practices. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Havranek's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Havranek is licensed in Colorado.

CMS data shows 238 Medicare services from Dr. Havranek across 3 procedure codes in 2024, for 205 Medicare patients. Medicare paid $3,374 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 205 Medicare patients who saw Dr. Havranek in 2024. The largest group is 65 to 74, with 89 patients. 74% of them have high blood pressure, and 52% have high cholesterol. 66% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Havranek's median patient age at 69, with 48% women.

In 2024, Dr. Havranek wrote 248 Medicare Part D claims for 60 patients. 83% of them were for generic drugs. CMS names the drug for 135 of them, across 7 drugs with 11 or more claims each, at $1,284 in total drug cost. In 2023, CMS named 90 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Havranek for performance year 2024, reported as part of a group. Dr. Havranek accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Havranek as offering telehealth.

Dmand AI links 67 papers to Dr. Havranek, published from 2010 to 2024. 2019 was the busiest year, with 8. The most frequent topics are Colorado, Hypertension and Hispanic or Latino. Dr. Havranek has published most often in Circ Cardiovasc Qual Outcomes. Dr. Havranek's most frequent co-authors are Stacie Luther Daugherty, MD, Rebecca L. Hanratty, MD and Adit A. Ginde, MD.

CMS Open Payments shows 1 general payment to Dr. Havranek from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Astellas Pharma US Inc paid the most, $22.

Dr. Havranek graduated from University of Vermont College of Medicine in 1983.